Cargando…
Utilization of Clinical Pathways Can Reduce Drug Spend Within the Oncology Care Model
PURPOSE: Reducing drug spend is one of the greatest challenges for practices participating in the Oncology Care Model (OCM). Evidence-based clinical pathways have the potential to decrease drug spend while maintaining clinical outcomes consistent with published evidence. The goal of this study was t...
Autores principales: | Hertler, Andrew, Chau, Sang, Khetarpal, Rani, Bassin, Ed, Dang, Jeff, Koppel, Daniel, Damarla, Vijay, Wade, James |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Clinical Oncology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7224689/ https://www.ncbi.nlm.nih.gov/pubmed/32196401 http://dx.doi.org/10.1200/JOP.19.00753 |
Ejemplares similares
-
Fair regression for health care spending
por: Zink, Anna, et al.
Publicado: (2020) -
The Primary Care Spend Model: a systems approach to measuring investment in primary care
por: Baillieu, Robert, et al.
Publicado: (2019) -
Outpatient prescription drug spending by the Medicare population
por: Waldo, Daniel R.
Publicado: (1987) -
Variation in nomenclature of somatic variants for selection of oncological therapies: Can we reach a consensus soon?
por: Keppens, Cleo, et al.
Publicado: (2019) -
Can screening for low vitamin D levels prevent bone health complications in paediatric oncology patients?
por: Naeije, Leonie, et al.
Publicado: (2021)